There is a ‘sea change’ in treatment of restless legs syndrome. For the first time this year folks on the panel all agree starting with non-dopaminergic drugs may be the path forward. Pregabalin has a randomized trial. Others like dipyridamole (below) may be coming. @movedisorderpic.twitter.com/XERocspyA3
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 